TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Faun Pharma AS
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
104,185
|
98,660
|
120,734 |
Financial expenses |
394
|
201
|
251 |
Earnings before taxes |
4,200
|
1,999
|
8,094 |
Total assets |
33,302
|
32,217
|
29,293 |
Current assets |
26,337
|
24,083
|
23,798 |
Current liabilities |
7,232
|
7,875
|
10,421 |
Equity capital |
18,889
|
16,612
|
15,896 |
- share capital |
663
|
706
|
746 |
Employees (average) |
41
|
38 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
56.7%
|
51.6%
|
54.3% |
Turnover per employee |
2,406
|
3,177 | |
Profit as a percentage of turnover |
4.0%
|
2.0%
|
6.7% |
Return on assets (ROA) |
13.8%
|
6.8%
|
28.5% |
Current ratio |
364.2%
|
305.8%
|
228.4% |
Return on equity (ROE) |
22.2%
|
12.0%
|
50.9% |
Change turnover |
11,587
|
-15,732
|
6,914 |
Change turnover % |
13%
|
-14%
|
6% |
Chg. No. of employees | 3 | ||
Chg. No. of employees % | 8% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.